Adrenal disease

Inflammation-based Scores in Patients With Pheochromocytoma

J Clin Endocrinol MetabPublished Retrospective case-control study

Authors' conclusion

Inflammation-based scores in patients with pheochromocytoma showed pro-inflammatory changes that correlated with plasma metanephrine levels and are ameliorated by adrenalectomy and α-blockade.

Study context

Population
Patients with pheochromocytoma who underwent adrenalectomy (median age 53 years; 64.7% females) and matched controls
Participants
68 / 68 / 53
Comparison
Pheochromocytoma vs nonfunctioning adrenocortical tumors vs essential hypertension
  • Pheochromocytoman = 68
  • Nonfunctioning adrenocortical tumorsn = 68reference
  • Essential hypertensionn = 53reference
Outcome
Inflammation-based scores and correlation with plasma metanephrines
Methodological detailscontrols matched for age, sex and BMI
  • Controls matched for age, sex and BMI

Main finding

As reported in the abstract

Positive correlation of plasma metanephrines with NLR
r = 0.4631
Positive correlation of plasma metanephrines with PLR
r = 0.3174
Positive correlation of plasma metanephrines with SII
r = 0.3709
Negative correlation of plasma metanephrines with LMR
r = 0.4368
Negative correlation of plasma metanephrines with prognostic-nutrition index
r = 0.3741

Observational data: associations, not effects.

Further findings

Change in inflammation-based scores after adrenalectomy (n = 26)

Reduction in NLR
P = 0.001
Reduction in PLR
P = 0.003
Reduction in SII
P = 0.004
Increase in LMR
P = 0.0002

Change in inflammation-based scores with preoperative α-blockade (n = 29) · before vs after α-blockade

Reduction in NLR
P = 0.007
Reduction in SII
P = 0.03

Original publication

Inflammation-based Scores in Patients With Pheochromocytoma. J Clin Endocrinol Metab. Published 24 April 2024. doi:10.1210/clinem/dgae284

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.